PURE Bioscience, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
PURE Bioscience, Inc. (PURE) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $0 for the 9-month period ending 2014-04-30, per its 10-Q filed 2014-06-10.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2014-06-10
- PURE Bioscience, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2014-04-30 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|---|
| 2014-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-06-10 | $0.00 10-Q · filed 2014-06-10 | ||
| 2014-01-31 | $0.00 10-Q · filed 2014-03-13 | |||
| 2013-07-31 | $0.00 10-Q · filed 2014-06-10 |